Compare ESPR & YEXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESPR | YEXT |
|---|---|---|
| Founded | 2008 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 731.9M | 679.8M |
| IPO Year | 2013 | 2017 |
| Metric | ESPR | YEXT |
|---|---|---|
| Price | $3.13 | $3.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $8.75 | $7.50 |
| AVG Volume (30 Days) | ★ 9.9M | 1.1M |
| Earning Date | 05-07-2026 | 06-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 60.71 | ★ 131.82 |
| EPS | N/A | ★ 0.02 |
| Revenue | ★ $403,135,000.00 | $170,201,000.00 |
| Revenue This Year | N/A | $3.95 |
| Revenue Next Year | $12.81 | $2.46 |
| P/E Ratio | ★ N/A | $198.00 |
| Revenue Growth | ★ 21.31 | N/A |
| 52 Week Low | $0.95 | $3.27 |
| 52 Week High | $4.18 | $9.20 |
| Indicator | ESPR | YEXT |
|---|---|---|
| Relative Strength Index (RSI) | 69.52 | 47.94 |
| Support Level | $3.11 | $3.35 |
| Resistance Level | $3.18 | $4.14 |
| Average True Range (ATR) | 0.01 | 0.24 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 75.00 | 43.12 |
Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.
Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.